Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Orchid Ventures, Inc. (ORVRF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.09750.0000 (0.00%)
At close: 09:30AM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0975
Open0.0975
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0975 - 0.0975
52 Week Range0.0600 - 0.8000
Volume500
Avg. Volume1,599
Market Cap5.113M
Beta (5Y Monthly)2.46
PE Ratio (TTM)N/A
EPS (TTM)-0.1050
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    Orchid Ventures Announces the Appointment of a New CFO

    VANCOUVER, BC / ACCESSWIRE / January 21, 2022 / Orchid Ventures, Inc. (the "Company" or "Orchid") (CSE:ORCD)(OTC PINK:ORVRF), a multi-state cannabis innovation company, announced today that it has accepted the resignation of Yousuf Jaffar, CFO, and has appointed Richard Brown, President, as its new CFO effective January 17, 2022.

  • ACCESSWIRE

    Orchid Ventures Announces Partnership with Eurox Pharma GmbH on Submission to German Authorities for Medical Device Approval

    VANCOUVER, BC / ACCESSWIRE / January 11, 2022 / Orchid Ventures, Inc. (the "Company" or "Orchid") (CSE:ORCD) (OTC PINK:ORVRF), a multi-state cannabis innovation company, today announced it has entered into an exclusive agreement with Eurox Pharma GmbH ("EUROX"), Germany based pharmaceutical company.

  • ACCESSWIRE

    Orchid Ventures Announces AGM Results

    VANCOUVER, BC / ACCESSWIRE / December 14, 2021 / ORCHID VENTURES, INC. (CSE:ORCD; OTC:ORVRF) (the "Company" or "Orchid") is pleased to announce the results of voting at its annual general meeting (the "AGM") of shareholders ("Shareholders") held on December 10, 2021.

Advertisement
Advertisement